Taylor Schreiber
Founder en SHATTUCK LABS, INC. .
Fortuna: 25 M $ al 31/03/2024
Perfil
Taylor H.
Schreiber is the founder.
He founded Shattuck Labs, Inc. in 2016 and currently holds the title of Chief Executive Officer & Director.
He also held the position of Director at Pelican Therapeutics, Inc. from 2011 to 2017.
Additionally, he served as the Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Dr. Schreiber has an undergraduate degree from Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SHATTUCK LABS, INC.
5.81% | 12/01/2024 | 2 757 686 ( 5.81% ) | 25 M $ | 31/03/2024 |
Cargos activos de Taylor Schreiber
| Empresas | Cargo | Inicio |
|---|---|---|
| SHATTUCK LABS, INC. | Founder | 01/01/2016 |
Antiguos cargos conocidos de Taylor Schreiber.
| Empresas | Cargo | Fin |
|---|---|---|
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Director/Board Member | 01/01/2017 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Taylor Schreiber.
| Bucknell University | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
- Bolsa de valores
- Insiders
- Taylor Schreiber
